TMED vs. RAAR

Last updated Aug 4, 2026

TMED (T. Rowe Price Health Care ETF) and RAAR (Reckoner Yield Enhanced AAA CLO Reinvesting ETF) are both exchange-traded funds - TMED is a Health & Biotech Equities fund actively managed by T. Rowe Price, while RAAR is a Actively Managed fund actively managed by Reckoner. Both are actively managed. Their -0.02 correlation means they have often moved in opposite directions in the past. TMED charges 0.44%/yr vs 0.40%/yr for RAAR.

Performance

TMED vs. RAAR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in T. Rowe Price Health Care ETF (TMED) and Reckoner Yield Enhanced AAA CLO Reinvesting ETF (RAAR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

TMED

• 1D: 0.28%
• 1M: -2.90%
• 6M: 13.93%
• YTD: 14.31%
• 1Y: 41.69%
• 3Y*: —
• 5Y*: —
• 10Y*: —
• ALL TIME*: 31.40%

RAAR

• 1D: 0.01%
• 1M: 0.49%
• 6M: —
• YTD: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —
• ALL TIME*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
RAAR Reckoner Yield Enhanced AAA CLO Reinvesting ETF	$21.71K	$113.55K	$94.79K
TMED T. Rowe Price Health Care ETF	$590.48K	$387.83K	$177.93K

TMED vs. RAAR - Yearly Performance Comparison

	2026 (YTD)
TMED T. Rowe Price Health Care ETF	15.64%
RAAR Reckoner Yield Enhanced AAA CLO Reinvesting ETF	2.36%

Correlation

The correlation between TMED and RAAR is -0.02, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.

	Correlation
Correlation (All Time) Calculated using the full available price history since Feb 11, 2026	-0.02

Return for Risk

TMED vs. RAAR — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

TMED

TMED Risk / Return Rank: 87
TMED Sharpe Ratio Rank: 88
TMED Sortino Ratio Rank: 89
TMED Omega Ratio Rank: 85
TMED Calmar Ratio Rank: 87
TMED Martin Ratio Rank: 84

RAAR

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

TMED vs. RAAR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Health Care ETF (TMED) and Reckoner Yield Enhanced AAA CLO Reinvesting ETF (RAAR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	TMED	RAAR	Difference
Sharpe ratio: Return per unit of total volatility	2.29	—	—
Sortino ratio: Return per unit of downside risk	3.32	—	—
Omega ratio: Gain probability vs. loss probability	1.39	—	—
Calmar ratio: Return relative to maximum drawdown	3.77	—	—
Martin ratio: Return relative to average drawdown	12.83	—	—

Drawdowns

TMED vs. RAAR - Drawdown Comparison

The maximum TMED drawdown since its inception was -11.11%, which is greater than RAAR's maximum drawdown of -0.65%. Use the drawdown chart below to compare losses from any high point for TMED and RAAR.

Drawdown Indicators

	TMED	RAAR	Difference
Max Drawdown Largest peak-to-trough decline	-11.11%	-0.65%	-10.46%
Max Drawdown (1Y) Largest decline over 1 year	-11.11%	—	—
Current Drawdown Current decline from peak	-3.98%	0.00%	-3.98%
Average Drawdown Average peak-to-trough decline	-2.42%	-0.08%	-2.34%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.26%	—	—

Volatility

Volatility by Period

	TMED	RAAR	Difference
Volatility (1M) Calculated over the trailing 1-month period	4.81%	—	—
Volatility (6M) Calculated over the trailing 6-month period	14.06%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	18.29%	1.82%	+16.47%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	18.11%	1.82%	+16.29%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	18.11%	1.82%	+16.29%

TMED vs. RAAR - Expense Ratio Comparison

TMED has a 0.44% expense ratio, which is higher than RAAR's 0.40% expense ratio.

Dividends

TMED vs. RAAR - Dividend Comparison

TMED's dividend yield for the trailing twelve months is around 0.48%, while RAAR has not paid dividends to shareholders.

Position	TTM	2025
RAAR Reckoner Yield Enhanced AAA CLO Reinvesting ETF	0.00%	0.00%
TMED T. Rowe Price Health Care ETF	0.48%	0.54%

Frequently Asked Questions

Can I hold both TMED and RAAR in my portfolio?

TMED and RAAR have a correlation of -0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, TMED or RAAR?

On fees, RAAR is cheaper at 0.40% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, TMED or RAAR?

RAAR is cheaper with a 0.40% expense ratio, compared with 0.44% for TMED.

Which ETF pays a higher dividend yield, TMED or RAAR?

TMED has the higher dividend yield at 0.48%, compared with 0.00% for RAAR.

What is the main difference between TMED and RAAR?

TMED is categorized as Health & Biotech Equities, while RAAR is Actively Managed. They also come from different issuers: T. Rowe Price and Reckoner. Their fees differ too: 0.44% for TMED and 0.40% for RAAR.